Dermatology

Baricitinib (Olumiant; Eli Lilly and Incyte ) was found to produce significant hair regrowth on the scalp, eyelashes, and eyebrows of adults with severe alopecia areata.

Cortizone-10 is used to treat a variety of skin conditions.

In recent years, the auditing process has evolved into a full-blown investigation, often requiring pharmacies to submit hundreds of pages of documentation

Upadacitinib (Rinvoq) is a Janus kinase (JAK) inhibitor being investigated to treat rheumatoid arthritis, Crohn disease, ulcerative colitis, atopic dermatitis, psoriatic arthritis, axial SpA giant cell arteritis, and Takayasu arteritis

Odor-Eaters foot powder removes foot odor and offers possible wetness protection.

Gold Bond Ultimate treats or prevents dry, rough, scaly, itchy skin, as well as minor skin irritations.

Ixekizumab (Taltz) is indicated for the treatment of conditions such as plaque psoriasis, psoriatic arthritis, active ankylosing spondylitis, and non-radiographic axial spondyloarthritis.

Pharmacists can play a critical role in this therapy, panelists in a recent Pharmacy Times® Peer Exchange say.

If approved, Dipilumab will be the first biologic medicine available in the United States to treat uncontrolled moderate-to-severe AD for patients aged 6 months to 5 years.

Tralokinumab-ldrm is an interleukin-13 antagonist recently approved for the treatment of moderate-to-severe atopic dermatitis.

Sagely Naturals Pain Relief Cream combines CBD with powerful botanicals, peppermint, and menthol.

Ten quiz questions to assess your knowledge on common symptoms and treatments for psoriasis.

Tavaborole (Kerydin) is indicated for the topical treatment of onychomycosis of the toenails.

Ten quiz questions to assess your knowledge on common symptoms and treatments for atopic dermatitis.

Granuloma annulare is a skin condition that is not contagious and usually not painful.

Fungicure Medicated Anti-Fungal Wash helps eliminate common fungus that can attack healthy skin.

The 2 drugs are the first small molecule JAK-1 inhibitors to be approved in the United States as treatment options for patients who are not responding to other therapies.

DerMend treats or prevents dry, rough, scaly, and itchy skin, as well as minor skin irritations.

In a pair of pivotal studies, risankizumab-rzaa (Skyrizi) met the primary endpoint of American College of Rheumatology 20% improvement response at week 24 compared to placebo.

Researchers found similar improvements in dryness, redness, roughness, tightness, irritation, moisturization, smoothness, and overall skin appearance between the 2 products.

Several common houseplants present in homes year-round due to their low maintenance requirements and environmental adaptability are far more toxic than many may realize.

Exederm treats itching, inflammation, redness, and rash associated with eczema and dermatitis.

Oral apremilast achieved a clinically meaningful and statistically significant improvement in the primary endpoint of the modified static Physician’s Global Assessment of Genitalia response.

Across the trials, abrocitinib demonstrated a consistent safety profile and profound improvements in skin clearance, extent of disease, and severity.

Educate and remind patients to use appropriate OTC products to help protect, restore, and maintain the natural skin barrier.